Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Non-Current Assets (2021 - 2025)

Bioregenx's Non-Current Assets history spans 5 years, with the latest figure at $159721.0 for Q4 2025.

  • Quarterly results put Non-Current Assets at $159721.0 for Q4 2025, down 20.43% from a year ago — trailing twelve months through Dec 2025 was $2.1 million (down 95.95% YoY), and the annual figure for FY2025 was $159721.0, down 20.43%.
  • Non-Current Assets for Q4 2025 was $159721.0 at Bioregenx, down from $894608.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $18.1 million in Q1 2024 to a low of $31640.0 in Q4 2023.
  • The 5-year median for Non-Current Assets is $174041.5 (2025), against an average of $4.0 million.
  • The sharpest move saw Non-Current Assets skyrocketed 51040.25% in 2024, then crashed 98.96% in 2025.
  • Year by year, Non-Current Assets stood at $103404.0 in 2021, then plummeted by 43.45% to $58473.0 in 2022, then crashed by 45.89% to $31640.0 in 2023, then soared by 534.45% to $200739.0 in 2024, then decreased by 20.43% to $159721.0 in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $159721.0, $894608.0, and $900985.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.